BioMed Central will be exhibiting at the upcoming 18th Annual International Conference on Intelligent Systems for Molecular Biology (ISMB) in Boston, July 10-13. Come by booth 7 and learn about the new developments from our journals and check out the exciting giveaways we have. We are situated next door to our colleagues from Springer in… Read more »
“We have way more data than we can possibly analyse”, said Arthritis Research & Therapy Editorial Board member Prof Edward Wakeland, in concluding his keynote address to the 9th International Congress on Systemic Lupus Erythematosus in Vancouver. The Wakeland Laboratory are generating data that should help elucidate the genetic basis for human susceptibility to lupus…. Read more »
Springer Science+Business Media, BioMed Central’s parent company and one of the world’s largest Scientific, Technical and Medical (STM) publishers, today announced a significant expansion of its open access publishing activity with the launch of SpringerOpen (www.springeropen.com), a new series of open access journals that will span all STM disciplines. Articles published in SpringerOpen journals will be… Read more »
BioMed Central has recently launched two new gateways in the fields of Endocrinology and Gastroenterology, providing a useful resource to researchers in these disciplines where up-to-the minute information including relevant research, recent news and research highlights can easily be accessed. Each gateway features an item about a renowned author in the field who has chosen… Read more »
Last week, Universities UK and JISC held a conference to educate senior university managers about the importance of open access to institutions, how to develop policies and plan financing. A report presented at the conference demonstrates that a single large university could contribute around £3 million each year to the UK research community as a whole… Read more »
The newly released 2009 edition of Thomson Reuters’ Journal Citation Report includes official Impact Factors for 77 BioMed Central journals, 54 of which are new or improved. Some highlights: Genome Biology (IF 6.63) increased its Impact Factor and remains BioMed Central’s most highly cited journal. BMC Biology (IF 5.64) is now ranked #4 of 73… Read more »
The winners of BioMed Central’s 4th Annual Research Awards were announced at London’s Swiss Re Tower last week. The event was attended by shortlisted authors, eminent researchers, publishers, open access advocates and science journalists from around the world. The awards, now in their fourth year, acknowledge excellence in research that has been made universally accessible… Read more »